Cullinan Therapeutics(Cgem) Financials: Net Profit Margin Compared To Industry Average, Plus Other Key Ratios

Report Profitability Growth Liquidity Solvency Valuation

net profit margin operating profit margin

Company Report for CGEM

Report - net profit margin

This chart shows the historical trend of net profit margin for CGEM compared to its industry average over the recent years.

Ratio Definition and Interpretation

Name: Net Profit Margin

Definition: Net profit margin shows how much profit remains after paying all costs — including operating expenses, interest, and taxes — for every dollar of sales. A higher margin means the business is efficient and keeps more of its sales as bottom-line profit. Falling margins may signal rising costs or pricing pressure.

Interpretation:
• In '2021', CGEM's net profit margin was -346.1%, measuring the overall profitability of the company. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2021' stood at -219.6%.
Overall, CGEM's net profit margin has been volatile but generally stable over the past 1 years.

Formula: Net Profit Margin = Net Income / Revenue

Good Range: Ranges 5%-20% for many industries.